aav.104
aav.104: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Decibel Therapeutics, Inc. (DBTX) | Preclinical |
Get deeper analysis on aav.104
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis